FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323670183> ?p ?o ?g. }

• W4323670183 endingPage "445" @default.
• W4323670183 startingPage "438" @default.
• W4323670183 abstract "Introduction Non-Hodgkin lymphoma (NHL) is a heterogeneous disease, with each subtype associated with different risk factors. Within this group, diffuse large B-cell lymphoma (DLBCL) can be highlighted, the most common type of NHL.NK cells are key components of the innate immune response and may play an important antitumor role. Objective The objective of the present work was to determine the polymorphism of KIR genes in Brazilian patients with DLBCL. Materials and Methods Furthermore, we evaluated the association between the polymorphism of these genes and their ligands with the clinical course of the disease. For the study, 112 patients with DLBCL and 222 voluntary blood and bone marrow donors. The genetic material of these samples were extracted for KIR and HLA typing, determination of HLA ligands, determination of the KIR haplotype and search for the deletion of 22 bp in the KIR2DS4 gene. KIR genotype distributions were made by direct counting using 2 × 2 contingency tables using Fisher's exact test. The magnitude of the association was measured by odds ratio (OR) and 95% confidence interval. P values <.05 were considered significant. Overall survival and progression-free survival were assessed with a Kaplan-Meier estimator. Results In the present study, an association of HLA-Bw4 and HLA-Bw480I ligand was found with more advanced stages of the disease. Also, an association of the KIR2DL3 gene with a better response to treatment was found. Conclusion With this, we can conclude that the polymorphism of KIR genes and the association with HLA ligands can influence the prognosis of DLBCL, as well as the response to treatment was found. With this, we can conclude that the polymorphism of KIR genes and the association with HLA ligands can influence the prognosis of DLBCL, as well as the response to treatment.Non-Hodgkin lymphoma (NHL) is a heterogeneous disease, with each subtype associated with different risk factors. Within this group, diffuse large B-cell lymphoma (DLBCL) can be highlighted, the most common type of NHL.NK cells are key components of the innate immune response and may play an important antitumor role. The objective of the present work was to determine the polymorphism of KIR genes in Brazilian patients with DLBCL. Furthermore, we evaluated the association between the polymorphism of these genes and their ligands with the clinical course of the disease. For the study, 112 patients with DLBCL and 222 voluntary blood and bone marrow donors. The genetic material of these samples were extracted for KIR and HLA typing, determination of HLA ligands, determination of the KIR haplotype and search for the deletion of 22 bp in the KIR2DS4 gene. KIR genotype distributions were made by direct counting using 2 × 2 contingency tables using Fisher's exact test. The magnitude of the association was measured by odds ratio (OR) and 95% confidence interval. P values <.05 were considered significant. Overall survival and progression-free survival were assessed with a Kaplan-Meier estimator. In the present study, an association of HLA-Bw4 and HLA-Bw480I ligand was found with more advanced stages of the disease. Also, an association of the KIR2DL3 gene with a better response to treatment was found. With this, we can conclude that the polymorphism of KIR genes and the association with HLA ligands can influence the prognosis of DLBCL, as well as the response to treatment was found. With this, we can conclude that the polymorphism of KIR genes and the association with HLA ligands can influence the prognosis of DLBCL, as well as the response to treatment." @default.
• W4323670183 created "2023-03-10" @default.
• W4323670183 creator A5029371601 @default.
• W4323670183 creator A5038924976 @default.
• W4323670183 creator A5039491726 @default.
• W4323670183 creator A5050238686 @default.
• W4323670183 creator A5054796228 @default.
• W4323670183 creator A5060874612 @default.
• W4323670183 creator A5067612026 @default.
• W4323670183 creator A5071520162 @default.
• W4323670183 creator A5077831059 @default.
• W4323670183 date "2023-06-01" @default.
• W4323670183 modified "2023-10-17" @default.
• W4323670183 title "Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma" @default.
• W4323670183 cites W1020989877 @default.
• W4323670183 cites W1658165273 @default.
• W4323670183 cites W1986974587 @default.
• W4323670183 cites W1993395413 @default.
• W4323670183 cites W2003890249 @default.
• W4323670183 cites W2012843549 @default.
• W4323670183 cites W2020142884 @default.
• W4323670183 cites W2024288062 @default.
• W4323670183 cites W2028311823 @default.
• W4323670183 cites W2043969722 @default.
• W4323670183 cites W2044306036 @default.
• W4323670183 cites W2072244585 @default.
• W4323670183 cites W2073989522 @default.
• W4323670183 cites W2105845246 @default.
• W4323670183 cites W2107749930 @default.
• W4323670183 cites W2110395002 @default.
• W4323670183 cites W2131424155 @default.
• W4323670183 cites W2132756351 @default.
• W4323670183 cites W2147246240 @default.
• W4323670183 cites W2158804326 @default.
• W4323670183 cites W2165885469 @default.
• W4323670183 cites W2296584843 @default.
• W4323670183 cites W2395874338 @default.
• W4323670183 cites W2475299468 @default.
• W4323670183 cites W2487308472 @default.
• W4323670183 cites W2563063147 @default.
• W4323670183 cites W2585754738 @default.
• W4323670183 cites W2589987575 @default.
• W4323670183 cites W2614435853 @default.
• W4323670183 cites W2615984387 @default.
• W4323670183 cites W2737564796 @default.
• W4323670183 cites W2799290306 @default.
• W4323670183 cites W2799900329 @default.
• W4323670183 cites W2912012688 @default.
• W4323670183 cites W2921072067 @default.
• W4323670183 cites W2953490532 @default.
• W4323670183 cites W4236717099 @default.
• W4323670183 cites W4237846578 @default.
• W4323670183 doi "https://doi.org/10.1016/j.clml.2023.03.001" @default.
• W4323670183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37105848" @default.
• W4323670183 hasPublicationYear "2023" @default.
• W4323670183 type Work @default.
• W4323670183 citedByCount "1" @default.
• W4323670183 countsByYear W43236701832023 @default.
• W4323670183 crossrefType "journal-article" @default.
• W4323670183 hasAuthorship W4323670183A5029371601 @default.
• W4323670183 hasAuthorship W4323670183A5038924976 @default.
• W4323670183 hasAuthorship W4323670183A5039491726 @default.
• W4323670183 hasAuthorship W4323670183A5050238686 @default.
• W4323670183 hasAuthorship W4323670183A5054796228 @default.
• W4323670183 hasAuthorship W4323670183A5060874612 @default.
• W4323670183 hasAuthorship W4323670183A5067612026 @default.
• W4323670183 hasAuthorship W4323670183A5071520162 @default.
• W4323670183 hasAuthorship W4323670183A5077831059 @default.
• W4323670183 hasConcept C104317684 @default.
• W4323670183 hasConcept C126322002 @default.
• W4323670183 hasConcept C135763542 @default.
• W4323670183 hasConcept C143998085 @default.
• W4323670183 hasConcept C147483822 @default.
• W4323670183 hasConcept C156957248 @default.
• W4323670183 hasConcept C188280979 @default.
• W4323670183 hasConcept C197754878 @default.
• W4323670183 hasConcept C203014093 @default.
• W4323670183 hasConcept C2778559949 @default.
• W4323670183 hasConcept C2779338263 @default.
• W4323670183 hasConcept C54355233 @default.
• W4323670183 hasConcept C71924100 @default.
• W4323670183 hasConcept C86803240 @default.
• W4323670183 hasConceptScore W4323670183C104317684 @default.
• W4323670183 hasConceptScore W4323670183C126322002 @default.
• W4323670183 hasConceptScore W4323670183C135763542 @default.
• W4323670183 hasConceptScore W4323670183C143998085 @default.
• W4323670183 hasConceptScore W4323670183C147483822 @default.
• W4323670183 hasConceptScore W4323670183C156957248 @default.
• W4323670183 hasConceptScore W4323670183C188280979 @default.
• W4323670183 hasConceptScore W4323670183C197754878 @default.
• W4323670183 hasConceptScore W4323670183C203014093 @default.
• W4323670183 hasConceptScore W4323670183C2778559949 @default.
• W4323670183 hasConceptScore W4323670183C2779338263 @default.
• W4323670183 hasConceptScore W4323670183C54355233 @default.
• W4323670183 hasConceptScore W4323670183C71924100 @default.
• W4323670183 hasConceptScore W4323670183C86803240 @default.
• W4323670183 hasIssue "6" @default.
• W4323670183 hasLocation W43236701831 @default.

• next